The UTSW Small Animal SPECT-CT for Molecular Imaging Research and Education
The UTSW Small Animal SPECT-CT for Molecular Imaging Research and Education
批准号:
7843162
负责人:
Orhan Kemal Oz
金额:
$89.41万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-08 至 2011-07-07
关键词:
AmericanAnimal ModelAnimalsAreaArthritisAutoimmunityBiologyCardiovascular systemDiseaseDisease ProgressionEducationFundingGrantHealthcareImageLeadLupusManufacturer NameModelingMolecularMonitorMusNeurobiologyOccupationsPathogenesisPhotonsPlantsPriceRadiochemistryRattusResearchResearch PersonnelResolutionScanningScientistSiteSite VisitTreatment EfficacyUnited States National Institutes of HealthValidationVendorbasehuman diseaseimprovedin vivomolecular imagingneuro-oncologynext generationoncologyprogramspublic health relevanceradiologistradiotracervirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):: The objective of this application is the purchase of a BioScan NanoSPECT-CT scanner for in vivo small animal scanning. The requested purchase price is $1,063,916. Acquisition of the scanner will fulfill an unmet campus- wide need: high resolution small animal imaging in mice and rats injected with single photon emitting radiotracers. The scanner will permit a distinguished group of 13 NIH funded scientists to more optimally use animal models that have been created over years. A total of 21 NIH grants are supported in areas of neurobiology and neuro-oncology, cardiovascular biology and disease, arthritis, autoimmunity (lupus), oncology, and radiochemistry. Furthermore, we envisage a program in which the scanner will partially fulfill the educational imaging needs of the next generation molecular imagers and radiologists. The scanner was chosen after receiving quotes from the manufacturers. A team of 3 scientists, comprised of the PI (Radiologist- scientist), physicist, and a radiochemist, was formed to primarily evaluate the available commercial scanners. Site visits to installation sites, manufacturer's plants, or virtual demos were conducted for each of the major vendors. Scanner resolution, sensitivity, installed base, and ease of use were the dominant factors after considering the needs of the major users. The BioScan NanoSPECT-CT was considered the best choice for our users. Purchase of the scanner will lead to an immediate creation of 2 new jobs at UT Southwestern. Once investigators successfully use the scanner it is likely new funding will result that might lead to other jobs. The understanding that will result from application of SPECT/CT imaging of models of human disease may potentially lead to new therapies and improved healthcare for the American people.
PUBLIC HEALTH RELEVANCE: Small animal models of human diseases are important for advancing understanding of disease pathogenesis and disease treatment. Imaging studies in these animal models are critical for model validation, to follow disease progression, to monitor therapy efficacy, and minimize animal use. Purchasing the scanner will enhance research in these areas, potentially improve healthcare, and lead to creation of two jobs.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.
Bavituximab(一种具有血管靶向和免疫调节特性的磷脂酰丝氨酸靶向单克隆抗体)在肺癌异种移植物中的肿瘤特异性靶向。
DOI:
--
发表时间:
2015
期刊:
American journal of nuclear medicine and molecular imaging
影响因子:
2.5
作者:
[Gerber,DavidE, Hao,Guiyang, Watkins,Linda, Stafford,JasonH, Anderson,Jon, Holbein,Blair, Öz,OrhanK, Mathews,Dana, Thorpe,PhilipE, Hassan,Gedaa, Kumar,Amit, Brekken,RolfA, Sun,Xiankai]
通讯作者:
Sun,Xiankai
DOI:
10.1002/anie.201203031
发表时间:
2012-10
期刊:
Angewandte Chemie
影响因子:
--
作者:
[Chen Zhou;G. Hao;P. Thomas;Jinbin Liu;Mengxiao Yu;Shasha Sun;Orhan K Öz;Xiankai Sun;Jie Zheng-Jie-Zh]
通讯作者:
Chen Zhou;G. Hao;P. Thomas;Jinbin Liu;Mengxiao Yu;Shasha Sun;Orhan K Öz;Xiankai Sun;Jie Zheng-Jie-Zh
A comparative study of trans- and cis-isomers of a bone-seeking agent, DO2A2P.
寻骨剂 DO2A2P 反式和顺式异构体的比较研究。
DOI:
10.1016/j.bmcl.2014.12.016
发表时间:
2015
期刊:
Bioorganic & medicinal chemistry letters
影响因子:
2.7
作者:
[Hao,Guiyang, Liu,Wei, Hassan,Gedaa, Öz,OrhanK, Kovacs,Zoltan, Sun,Xiankai]
通讯作者:
Sun,Xiankai
DOI:
10.1038/s41598-021-82812-1
发表时间:
2021-02-11
期刊:
Scientific reports
影响因子:
4.6
作者:
[Hao G, Mastren T, Silvers W, Hassan G, Öz OK, Sun X]
通讯作者:
Sun X
Noninvasive Assessment of Pancreatic Beta-Cell Mass
-
批准号:8150302
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2011
-
负责人:Orhan Kemal Oz
-
依托单位:
Noninvasive Assessment of Pancreatic Beta-Cell Mass
-
批准号:8538959
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2011
-
负责人:Orhan Kemal Oz
-
依托单位:
Noninvasive Assessment of Pancreatic Beta-Cell Mass
-
批准号:8324517
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2011
-
负责人:Orhan Kemal Oz
-
依托单位:
THE ROLE OF ESTROGEN IN BONE METABOLISM
-
批准号:6636737
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2000
-
负责人:Orhan Kemal Oz
-
依托单位:
THE ROLE OF ESTROGEN IN BONE METABOLISM
-
批准号:6520643
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2000
-
负责人:Orhan Kemal Oz
-
依托单位:
THE ROLE OF ESTROGEN IN BONE METABOLISM
-
批准号:6096773
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2000
-
负责人:Orhan Kemal Oz
-
依托单位:
THE ROLE OF ESTROGEN IN BONE METABOLISM
-
批准号:6387396
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2000
-
负责人:Orhan Kemal Oz
-
依托单位:
THE ROLE OF ESTROGEN IN BONE METABOLISM
-
批准号:6733507
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2000
-
负责人:Orhan Kemal Oz
-
依托单位:
MARC PREDOCTORAL FELLOWSHIP
-
批准号:3024501
-
项目类别:
-
资助金额:$1.05万
-
财政年份:1987
-
负责人:Orhan Kemal Oz
-
依托单位:
MARC PREDOCTORAL FELLOWSHIP
-
批准号:3024500
-
项目类别:
-
资助金额:$1.04万
-
财政年份:1986
-
负责人:Orhan Kemal Oz
-
依托单位:
MARC PREDOCTORAL FELLOWSHIP
-
批准号:3024499
-
项目类别:
-
资助金额:$1.94万
-
财政年份:1985
-
负责人:Orhan Kemal Oz
-
依托单位:
海外基金